ArticleThe American journal of case reports2026
Diagnostic Value of Next-Generation Sequencing (NGS) and Microarray in Characterizing Tumor Origin: A Challenging and Educational Case.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND This report describes the case of an 81-year-old woman with a history of resected right-lung adenocarcinoma and presenting with a solitary nodule in the head of the pancreas, which demonstrated diagnostic challenges differentiating between metastasis of lung cancer versus primary pancreatic adenocarcinoma during the pathology workup. Differentiating between primary and metastasis in an isolated pancreatic lesion in a patient with a history of lung carcinoma is critical for patient treatment and management. Histology comparison, immunohistochemical characterization, and molecular studies, including next-generation sequencing (NGS) and microarray, are often utilized to differentiate between these two. CASE REPORT An 81-year-old woman with history of surgically resected right-lung adenocarcinoma in 2016 followed by adjuvant chemotherapy, presented in December 2024 with a solitary hypermetabolic pancreatic head nodule on positron emission tomography-computed tomography (PET CT). Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of the pancreas lesion was consistent with moderately differentiated adenocarcinoma, showing overlapping histologic morphology and immunohistochemical profile with her prior lung adenocarcinoma. NGS identified genetic alterations favoring a lung origin. However, microarray analysis utilizing real-time RT-PCR done on the subsequently resected pancreas mass classified the lesion as more likely to be of gastrointestinal/pancreatobiliary, rather than lung origin. CONCLUSIONS Differentiating between primary versus metastasis from the lungs in a patient with an isolated pancreatic adenocarcinoma with a history of lung adenocarcinoma can be challenging, and occasionally a definite conclusion is still difficult to reach after comprehensive workups. Driver gene mutations, if present, which can be detected by NGS, may be more reliable in predicting tumor origin/type.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.